AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment-Reference-Cited by-同舟云学术

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment

Published:2014-07-31 Issue:1 Volume:12 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Caputo Emilia,Miceli Roberta,Motti Maria Letizia,Taté Rosarita,Fratangelo Federica,Botti Gerardo,Mozzillo Nicola,Carriero Maria Vincenza,Cavalcanti Ernesta,Palmieri Giuseppe,Ciliberto Gennaro,Pirozzi Giuseppe,Ascierto Paolo Antonio

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-014-0216-z.pdf

Reference39 articles.

1. Lens MB, Dawes M: Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004, 150: 179-185. 10.1111/j.1365-2133.2004.05708.x.

2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin. 2009, 59: 225-249. 10.3322/caac.20006.

3. Inumaru JS, Gordo KI, Fraga Junior AC, Silva AM, Leal CB, Ayres FM, Wastowski IJ, Borges NF, Saddi VA: Analysis of the BRAF V600E mutation in primary cutaneous melanoma. Genet Mol Res. 2014, 13: 2840-2848. 10.4238/2014.January.22.8.

4. Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford RF: Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol. 2011, 29: 1239-1246. 10.1200/JCO.2010.32.4327.

5. Sullivan RJ, Flaherty K: MAP kinase signaling and inhibition in melanoma. Oncogene. 2013, 32: 2373-2379. 10.1038/onc.2012.345.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non–small Cell Lung Cancers;Cancer Research Communications;2024-05-08

2. Combination of AURKA inhibitor and MEK inhibitor strongly enhances G1 arrest and induces synergistic antitumor effect on KRAS or BRAF mutant colon cancer cells;2024-05-06

3. Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques;The International Journal of Biological Markers;2024-02-26

4. Actionable Genetic Screens Unveil Targeting of AURKA, MEK, and Fatty Acid Metabolism as an Alternative Therapeutic Approach for Advanced Melanoma;Journal of Investigative Dermatology;2023-10

5. A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2023-06-02